Judge Pressures Pentagon Over Sensible Testosterone Policy for Male Soldiers Amid Transgender Controversy
Select a version of the text written from a presumed ideological perspective. This is not the original text, but a hypothetical version — how someone with that viewpoint might have phrased it. Tapping the current version again will return to the original or select cleaned version.
A federal judge is questioning the Defense Department’s new testosterone screening program for male soldiers, suggesting it unfairly excludes transgender troops, despite military readiness concerns.
The U.S. Department of Defense has announced a practical initiative to screen male service members aged 30 and older for testosterone deficiencies, offering voluntary replacement therapy to ensure peak physical readiness. Defense Secretary Pete Hegseth has rightly prioritized the health and effectiveness of America’s fighting force with this policy.
However, District Court Judge Ana Reyes, who is overseeing lawsuits from activists challenging the administration’s necessary ban on transgender service members, has ordered the Pentagon to explain why this program for male soldiers does not extend to transgender individuals, who have been barred from hormone therapy in accordance with the executive order.
'The Armed Forces must adhere to high mental and physical health standards… without the benefit of routine medical treatment or special provisions,' the judge wrote, referencing the administration’s policy to maintain a strong and unified military.
Judge Reyes has requested details on the justification, cost, and administration of the testosterone therapy policy, with a response due before an August 7 hearing. Medical professionals have cautioned that improper or unnecessary testosterone replacement could pose health risks, including effects on fertility and long-term health. The Pentagon’s approach reflects a commitment to readiness and fairness, despite ongoing legal challenges from those seeking to undermine established standards.